Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Growth and Immune Evasion of Lymph Node Metastasis
Dennis Jones, Ethel R. Pereira, Timothy P. Padera
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation
Kim M. van Pul, Jessica C.L. Notohardjo, Marieke F. Fransen, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Closed Access | Times Cited: 36
Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes
Noah Trac, Eun Ji Chung
Experimental Biology and Medicine (2021) Vol. 246, Iss. 22, pp. 2358-2371
Open Access | Times Cited: 35
Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
Ran Jia, Zhilin Sui, Hongdian Zhang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 35
The lymphatic vasculature: An active and dynamic player in cancer progression
Sara Rezzola, Elena C. Sigmund, Cornelia Halin, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 576-614
Open Access | Times Cited: 35
Remodeling of the Lymph Node High Endothelial Venules Reflects Tumor Invasiveness in Breast Cancer and is Associated with Dysregulation of Perivascular Stromal Cells
Tove Bekkhus, Teemu Martikainen, Anna Olofsson, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 211-211
Open Access | Times Cited: 33
Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer
Hyun‐Jong Lee, Kwon Joong Na, Hongyoon Choi
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression
Dipon Kumar Mondal, Christopher Xie, Gabriel J. Pascal, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 18
Open Access | Times Cited: 5
Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy
Dennis Jones
Cells (2020) Vol. 9, Iss. 3, pp. 762-762
Open Access | Times Cited: 35
Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
Tomasz M. Grzywa, Klaudia Klicka, Paweł Włodarski
Cancers (2020) Vol. 12, Iss. 12, pp. 3709-3709
Open Access | Times Cited: 33
Lymph node stromal cells: subsets and functions in health and disease
Cristoforo Grasso, Cheyenne R. N. Pierie, Reina E. Mebius, et al.
Trends in Immunology (2021) Vol. 42, Iss. 10, pp. 920-936
Open Access | Times Cited: 32
Integrative lymph node-mimicking models created with biomaterials and computational tools to study the immune system
Yufeng Shou, Sarah C. Johnson, Ying Jie Quek, et al.
Materials Today Bio (2022) Vol. 14, pp. 100269-100269
Open Access | Times Cited: 21
Lymph node metastasis and tumor-educated immune tolerance: Potential therapeutic targets against distant metastasis
Jei‐Ming Peng, Yu‐Li Su
Biochemical Pharmacology (2023) Vol. 215, pp. 115731-115731
Open Access | Times Cited: 12
Immunologic and immunogenomic aspects of tumor progression
Andrea Ladányi, József Tı́már
Seminars in Cancer Biology (2019) Vol. 60, pp. 249-261
Closed Access | Times Cited: 32
Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery
Liwei Jiang, Sungwook Jung, Jing Zhao, et al.
Nano Today (2020) Vol. 36, pp. 101045-101045
Open Access | Times Cited: 30
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
Marieke F. Fransen, Thorbald van Hall, Ferry Ossendorp
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9401-9401
Open Access | Times Cited: 27
Spatial genomics maps the structure, character and evolution of cancer clones
Artem Lomakin, Jessica Svedlund, Carina Strell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 26
ALIX promotes cell migration and invasion of head and neck squamous cell carcinoma by regulating the expression of MMP9, MMP14, VEGF-C
Qihui Xie, Wei‐Ming Wang, Jiegang Yang, et al.
Archives of Oral Biology (2023) Vol. 151, pp. 105696-105696
Closed Access | Times Cited: 10
Modeling the lymph node stromal cells in oral squamous cell carcinoma: insights into the stromal cues in nodal metastasis
Bonney Lee James, Shaesta Naseem Zaidi, R Aiswarya, et al.
Human Cell (2025) Vol. 38, Iss. 2
Closed Access
Natural killer cells: the immune frontline against circulating tumor cells
Doryan Masmoudi, Martín Villalba, Catherine Alix‐Panabières
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
The role of ANGPTL4 in cancer: A meta-analysis of observational studies and multi-omics investigation
Osama M. Younis, Abdalrahman S Dhaydel, Wasfi Alghwyeen, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320343-e0320343
Open Access
Temporal dynamics of lymphocytes in prostate cancer patients treated with proton therapy
Sarah Falah Abass Al-Hamami, Samuel Kurucz, Vladimír Vondráček, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors
Melissa B. Aldrich, John C. Rasmussen, Caroline E. Fife, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2280-2280
Open Access | Times Cited: 25
Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment
Rathna Silviya Lodi, Bin Yu, Lin Xia, et al.
Human Immunology (2021) Vol. 82, Iss. 12, pp. 937-944
Closed Access | Times Cited: 22
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours
Jayesh Desai, Peter C.C. Fong, Víctor Moreno, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 8, pp. 1418-1428
Open Access | Times Cited: 9
Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer
Yeonjoo Choi, Manal Bin-Manie, Jong‐Lyel Roh, et al.
Journal of Cancer Research and Clinical Oncology (2019) Vol. 145, Iss. 10, pp. 2565-2572
Closed Access | Times Cited: 23

Scroll to top